Skip to contentI
Integra Lifesciences Holdings Corp
I
IARTIntegra Lifesciences Holdings Corp Q1 2015 · 10-Q
Revenue$202.53M$202.53M−5.8% vs Q1 2014 Net Income$8.38M$8.38M+280.1% vs Q1 2014 EPS Diluted$0.13$0.13+85.7% vs Q1 2014 Gross Profit$127,313,000+13.1% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Integra Lifesciences Holdings Corp · CIK 917520 · Engraved from SEC EDGAR
Operating Cash Flow$31,619,000+181.0% Free Cash Flowderived$26,289,000N/M Margins · derivedGross margin62.9%+10.5 pt vs Q1 2014
Operating margin10.5%+6.4 pt vs Q1 2014
Net margin4.1%+3.1 pt vs Q1 2014
ended Mar 31, 2015 · filed May 1, 2015 · 31 d after period end